Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.

C Bokemeyer; H J Schmoll; B Metzner; J Beyer; H J Illiger; M Kneba; H Ostermann; B Kynast; U Räth; H Poliwoda

doi:10.1007/BF01788130

Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.

Identifier:nobleid.org/w1/20260515/AB99CEFF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AB99CEFF.svg?ark=w1%2F20260515%2FAB99CEFF)](https://nobleid.org/work/w1/20260515/AB99CEFF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.

Identifier:nobleid.org/w1/20260515/AB99CEFF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AB99CEFF.svg?ark=w1%2F20260515%2FAB99CEFF)](https://nobleid.org/work/w1/20260515/AB99CEFF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work